NetScientific healthcare technology group

NetScientific is a transatlantic healthcare IP commercialisation group.
We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.

Our Portfolio

Targeting chronic diseases

Glycotest

Core Portfolio, Diagnostics

Glycotest Glycotest is a US-based liver diagnostics company seeking to commercialise …

ProAxsis

Core Portfolio, Diagnostics

ProAxsis ProAxsis is a medical diagnostics company based in Northern Ireland, …

PDS Biotechnology

Core Portfolio, Therapeutics

PDS Biotechnology PDS is a clinical stage immunotherapy company developing a …

G-Tech Medical

Digital health, Seed Portfolio

G-Tech Medical G-Tech Medical is developing a wireless, wearable, disposable patch …

Neumitra

Digital health, Seed Portfolio

Neumitra Neumitra develops embedded biomodules to accurately and continuously measure how …

Longevity Biotech

Seed Portfolio, Therapeutics

Longevity Biotech Overview Longevity Biotech (LBT) is developing a new class …

Epibone

Seed Portfolio, Therapeutics

Epibone EpiBone’s pioneering technology uses a scan of the patient’s bone …

Cytovale

Microfluidics, Seed Portfolio

Cytovale CytoVale is pioneering a new class of biomarkers. Disease states …

See our Portfolio

OUR TEAM

Sector-specialist senior management team with extensive commercial experience.

Sir Richard Sykes, FRS
Sir Richard Sykes, Non-Executive Chairman of the Group, joined NetScientific in 2008. Sir Richard spent thirty years working in the biotechnology and pharmaceutical industries, …

Sir Richard Sykes, FRS
Chairman
Ian Postlethwaite
Ian Postlethwaite, Chief Executive Office, Chief Financial Officer & Company Secretary, joined NetScientific in June 2016. He brings over 14 years of biopharma experience …

Ian Postlethwaite
Chief Executive Officer, Chief Financial Officer & Company Secretary

See our Team

NEWS

PDS second quarter 2019 financial results

Aug 1, 2019

News, PDS Biotechnology, RNS Announcements

1 August 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Corporation …

6 MIN READ

PDS Biotechnology Corporation liquidity funding program

Jul 31, 2019

News, PDS Biotechnology, RNS Announcements

31 July 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Corporation …

2 MIN READ

Results of Annual General Meeting

Jun 18, 2019

News, RNS Announcements

NetScientific plc (“NetScientific” or the “Company”) Result of Annual General Meeting London, UK – 18th June 2019 – NetScientific plc (AIM: NSCI), the transatlantic healthcare IP …

1 MIN READ

NetScientific is a transatlantic healthcare IP commercialisation group. We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.